A Case Report on Metamizole-Induced Agranulocytosis: Is the Benefit Worth the Risk?

Metamizole is a drug with analgesic and antipyretic properties widely available in Portugal. Its use is highly controversial because of the risk of agranulocytosis, a rare but serious adverse event. A 70-year-old female patient with a recent history of treatment with metamizole for post-surgery feve...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Rita, Henriques, Célia, Fernandes, Marco, Gouveia, Cláudio, Gama, Catarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981226/
https://www.ncbi.nlm.nih.gov/pubmed/36874711
http://dx.doi.org/10.7759/cureus.34467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981226/
https://www.ncbi.nlm.nih.gov/pubmed/36874711
http://dx.doi.org/10.7759/cureus.34467

Ejemplares similares